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ABSTRACT
The BloodChIP database (http://www.med.unsw.
edu.au/CRCWeb.nsf/page/BloodChIP) supports
exploration and visualization of combinatorial tran-
scription factor (TF) binding at a particular locus in
human CD34-positive and other normal and leu-
kaemic cells or retrieval of target gene sets for
user-defined combinations of TFs across one or
more cell types. Increasing numbers of genome-
wide TF binding profiles are being added to public
repositories, and this trend is likely to continue. For
the power of these data sets to be fully harnessed
by experimental scientists, there is a need for these
data to be placed in context and easily accessible
for downstream applications. To this end, we have
built a user-friendly database that has at its core the
genome-wide binding profiles of seven key haem-
atopoietic TFs in human stem/progenitor cells.
These binding profiles are compared with binding
profiles in normal differentiated and leukaemic
cells. We have integrated these TF binding profiles
with chromatin marks and expression data in
normal and leukaemic cell fractions. All queries
can be exported into external sites to construct
TF–gene and protein–protein networks and to
evaluate the association of genes with cellular
processes and tissue expression.
INTRODUCTION
Transcription factors (TFs) and the cis-regulatory se-
quences to which they bind form the building blocks of
gene regulatory networks that govern gene expression and
give cells their unique identity (1). Stem cells have the
capacity to regenerate themselves and also to give rise to
progeny with increasingly specialized function and re-
stricted proliferative capacity (2). Haematopoiesis is one
of the best described developmental systems in vertebrates
and serves as a model system for the multi-lineage differ-
entiation of adult stem cells. However, little is known
about the components and hierarchy of the gene regula-
tory network that controls the identity of human adult
haematopoietic stem cells (HSCs). Understanding the
ground state of the transcriptional network in HSCs is
the first step to better understanding how these networks
change as HSCs respond to external cues and proliferate
or differentiate. Stem cell signatures are also corrupted
and persist in leukaemic cells and confer an adverse prog-
nosis (3,4). Knowledge of the components and hierarchy
of the normal HSC transcriptional network may provide
clues to dismantling stem cell networks in leukaemic cells.
TFs often act in 3-D space as components of multi-
protein complexes that bind distal regulatory elements
and interact with promoters to initiate, augment or
suppress gene expression in conjunction with a plethora
of chromatin modifiers and transcription initiation/
elongation factors (5). In the post-genomics era, classical
methods to screen for potential gene-regulatory regions,
such as DNaseI hypersensitivity mapping by Southern
blotting of selected loci, have been superseded by
new genome-wide techniques such as Chromatin
Immunoprecipitation (ChIP) and DNaseI hypersensitivity
assays coupled to high throughput sequencing (ChIP-seq
and DNaseI-seq, respectively) (6,7). These large-scale
screening techniques help rapidly identify the positions
of a large number of candidate regulatory elements and
genome-wide binding patterns for multiple TFs.
A core set of seven TFs—FLI1, ERG, GATA2,
RUNX1, SCL/TAL1, LYL1 and LMO2—work in com-
bination to regulate gene expression in haematopoietic
stem/progenitor cells (HSPCs) (8). This heptad of TFs
also contributes to stem cell-like signatures in leukaemic
cells, and their presence impacts adversely on patient
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survival (4). Knowledge of how these TFs cooperate with
each other and interact with other lineage-specific TFs to
regulate gene expression during HSPC differentiation is
vital to improving our understanding of normal blood
development. To this end, we have recently generated
high-quality ChIP-seq data for these seven haematopoietic
TFs in primary human CD34+blood stem and progenitor
cells (9). To optimize the utility of these data, we
have integrated our ChIP-seq and RNA-seq data sets
with chromatin accessibility marks from the Human
Epigenome Atlas (6) and Encyclopaedia of DNA
Elements (ENCODE) (10) as well as published ChIP-seq
and expression data from normal (11–13) and leukaemic
stem cell fractions (14). All analysed and filtered data sets
can be exported for downstream analysis. To facilitate this
process, we have also created links to external resources
such as the UCSC genome browser to visualize data,
Cytoscape (15) and STRING (16) to construct TF–gene
and protein–protein networks and the Gene Expression
Atlas (17) to query expression in other data sets and
Gene Set Enrichment Analysis (GSEA) (18) to associate
a list of genes with cellular processes.
MATERIALS AND METHODS
Data sources
All data sources are summarized in Supplementary
Table S1 and a schematic diagram illustrating data sets
and features of BloodChIP is shown in Figure 1.
TF ChIP-seq
Genome-wide TF binding profiles for Human CD34+
HSPC (GSE45144), megakaryocytes (GSE24674), the
acute myeloid leukemia (AML) cell line SKNO-1
(GSE23730) and K562 (GSE24779, GSE29196,
GSE31477) were obtained from the Gene Expression
Omnibus (GEO) (9,12,19–21). To standardize the way
TF binding sites are obtained from the data set, peak
calling was performed using an improved automated
pipeline that we used previously to analyse the Human
CD34+ HSPC data set (9). Briefly, sequencing reads
were aligned to the hg19 reference genome using
Burrows-Wheeler Aligner (BWA) (22). Peak calling was
performed using three peak calling algorithms, HOMER
(23), MACS (24) and SPP (25). Only peaks that were
called by two or more of the algorithms are kept as part
of the final peak list. Aligned reads were also extended
to 200 bp to generated TF-binding genome coverage
profiles for visualization on the UCSC genome browser.
A schematic diagram illustrating the pipeline is shown in
Figure 2.
To obtain a uniform set of TF binding sites across all
TFs and across all cell lines, all peaks were merged. This
was achieved by sequentially merging overlapping peaks
across pairs of data set until all data sets have been
merged. Each region was then marked as either bound
or unbound for each TF data set. TF binding peaks
were mapped to nearby genes using the genomic regions
enrichment of annotations tool (GREAT) (26), which
defines genomic neighbourhoods for TF-bound peaks by
assigning weights to flanking genes based on their distance
to the peak.
Histone ChIP-seq
Histone ChIP-seq profiles from mobilized CD34+ cells
and K562 cells were obtained from the NIH Roadmap
Epigenomics Project (GSE18927) (6) and the ENCODE
project (GSE29611) (21), respectively. Histone profiles for
H3K27Ac, H3K4me1 and H3K4me3 were analysed, and
binding was quantified by counting the number to tags
mapping to 1.5 kbs adjacent to the centre of each TF
binding site. A read count of greater than 10 tags was
used as evidence for the presence of a particular histone
mark, which has been shown previously to adequately dis-
tinguish true signal from noise (9).
Gene expression
Genome-wide microarray expression data for human
normal CD34+ cells (GSE30029) (27), SKNO-1 cells
(GSE34594) (28) and K562 (GSE28135) (29) were
obtained from GEO (30), and expression data for
megakaryocytes (E-TABM-633) (11) was obtained from
ArrayExpress (31). Illumina expression arrays were used
in all of the above studies, the non-normalized expression
data from each data set was log2 transformed and quantile
normalized across all samples together for all cell types.
Where multiple microarray probes are available for one
gene, the probe with the highest average expression value
across all samples was selected to represent the expression
of the gene.
Genome-wide expression data comparing the stem and
progenitor sub-fractions of human CD34+cells of normal
donors and AML patients was obtained from GEO
(GSE24006) (14). Expression was measured on an
Affymetrix array. Robust Multi-chip Average approach
was used for normalization and expression levels
summarized. Probes were mapped to respective genes
and expression values for each gene were stored in the
database.
DNaseI hypersensitive site and digital genomic
footprints
For analysis of chromatin accessibility and digital genomic
footprints, annotations for mobilized CD34+ cells and
K562 cells (GSM646567) were obtained from previously
published data (32). A TF bound region was annotated
as chromatin accessible if the peak region overlapped
with a DNase I hypersensitive site (HS) region.
Furthermore, the number of digital genomic footprints
was counted within each DNase I HS region.
Database implementation, web interface and availability
All processed data were stored in a local MySQL (version
5.5.8) relational database. A web interface has been
designed to provide user-friendly access for database
query and visualization of TF binding and gene expression
through PHP-based scripts. The web interface is ac-
cessible at: http://www.med.unsw.edu.au/CRCWeb.nsf/
page/bloodChIP. BloodChIP also supports REST
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Figure 2. Schematic illustrating the ChIP-seq data analysis pipeline used for processing of ChIP-seq data sets used to populate the BloodChIP
database. The two outputs from the pipeline are the genome coverage profiles for visualization in UCSC and a list of transcription factor binding
sites.
Figure 1. Schematic summarizing data currently held by the BloodChIP database and features of the web interface. The database integrates TF
ChIP-seq, histone ChIP-seq, DNase I/digital genomic footprinting (DGF) and expression microarray data. The web interface provides methods to
query and visualize data and further links to external databases for further data analysis.
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(REpresentational State Transfer) Web Services to enable
programmatic access to the database. A tutorial is
provided at the BloodChIP web page describing the use
of the REST service. All data from BloodChIP are also
available for download as SQL files.
RESULTS: DATABASE FEATURES
General web interface
By default, the web interface to the database displays a
main table that lists all 23 804 genes in the human genome
as a sortable table (Supplementary Figure S1). For each
gene, the total number of heptad ChIP-seq peaks
associated with the gene is shown. A link to the UCSC
genome browser is also provided to allow visualization of
tracks for TF ChIP-seq, histone profiles and DNaseI HS
at the respective gene locus. Clicking on the row of each
gene will display the distribution of expression for a par-
ticular gene in CD34+, megakaryocytes, SKNO-1 and
K562 cells in the form of a box plot on the right of the
main table. This will also display checkboxes that indicate
TF binding associated with the particular gene.
To explore TF ChIP-seq peaks associated with a particu-
lar gene, the row containing the gene can be expanded. The
genomic coordinates of each peak is shown, along with red
boxes to indicate the binding of a particular TF from a
particular cell line at the particular peak. A blue box indi-
cates the absence of binding and a white box indicates that
the TF-binding profile is not present for the particular cell
type. The presence of each of the histone marks and DNase
I hypersensitivity is also shown. Finally, the number of
digital genomic footprints is also indicated. The binding
status of a maximum of seven TFs in three cell types can
be displayed on the web interface at any one time. The
specific TFs and cell types displayed can be customized
by the user using the display filter above the main table.
Querying the database
Two methods are available for querying the database
using the web interface, namely using gene symbol/
genomic coordinates and TF binding. For queries using
gene/genomic coordinate, a search dialogue is provided to
accept searches using the gene symbol, Refseq ID or
genomic coordinates in bed format. A user can either
paste in the query list or upload this as a file.
For retrieval of genes regulated by particular TF, a user
can select specific TFs for the different cell types available
in the database. A query can be constructed with any
combination of TFs to identify either genes that are com-
binatorially bound by multiple TFs (‘‘AND’’) or bound by
any of the TFs (‘‘OR’’). Furthermore, an option is avail-
able to filter the retrieved genes based on differential gene
expression between any of the cell types. A cut-off can be
specified to retain only genes that are above or below a
certain fold change threshold.
Links to external database and tools
To facilitate downstream analysis and data visualization,
hyperlinks taking advantage of external APIs are
provided. To further investigate the expression of a
single gene in other experiments, a link is provided to
the Gene Expression Atlas, displaying condition and
experiment-specific expression patterns of the gene of
interest. The Gene Expression Atlas is useful for the iden-
tification of publically available gene expression data sets
that can be used for further analysis and validation of
hypotheses.
To explore protein–protein interactions of the set of
genes displayed in main table, a link is provided to the
STRING database (16). The STRING database can be
used to reveal known and predicted physical and func-
tional protein interactions. This is particularly useful for
the discovery of major protein–protein interaction hubs
and for the prioritization of genes for further analysis.
Exporting data
The web interface provides four methods for the exporting
of data from a queried set of genes. Firstly, TF binding
information can be exported for individual genes in tab-
delimited format. Secondly, the normalized expression
values of all genes retrieved by a query for all samples
can be exported. This facilitates external analysis such as
clustering of genes or the generation of heatmaps. Thirdly,
the set of genes retrieved from the query can be exported
as a gene set for use in GSEA. Finally, to allow the visu-
alization of the TF–gene regulatory network, a file can be
exported in a format that can be immediately visualized
and analysed using the Cytoscape software package.
Utility of BloodChIP: a working example
If the user is interested in retrieving TF binding data at the
RUNX1 locus, a query for RUNX1 is initiated by typing in
the gene name or gene coordinates. The default settings
retrieve all combinations of binding sites with one or more
TF peaks that have been mapped to a locus by GREAT
(26) (Supplementary Figure S2A). The resulting view
shows peak coordinates in hCD34, Megakaryocytes and
AML cells with a link to the UCSC browser and a
checkerboard view of TF(s) bound to this region
(Supplementary Figure S2B). The Chr21: 36398905-
36399463 interval, which is bound by all seven TFs and
has active chromatin marks, corresponds to the Runx1+23
stem cell enhancer in mice (33).
This view also permits easy visualization of comparative
binding profiles at these or other regions in primary
megakaryocytes (12) and AML cells (20). The gene
expression view (Supplementary Figure S2C) to the right
shows RUNX1 expression across HSCs, multi-potent
progenitors (MPP), common myeloid progenitors
(CMP), granulocyte–monocyte progenitors (GMP) or
megakaryocyte–erythroid progenitor (MEP) fractions as
well as in AML leukaemic stem cells (LSC; Lin-/
CD34+/38-/CD90-), AML leukaemic progenitor cells
(Lin-/34+/38+) and AML blasts (Lin-/34-) (14),
megakaryocytes and AML cells. Had the biological
function of the +23 enhancer not been known, this
region would have been the prime candidate for functional
testing as a regulator of a gene that is both important for
normal blood development and is mutated in leukaemia.
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A tab at the top left corner permits easy export of data
contained in this view.
Alternatively, if the user wished to retrieve all targets for
RUNX1 alone or in combination with one or more TFs,
the appropriate options corresponding to the particular
cell type(s) of interest can be selected to yield a list of
genes that can either be viewed on UCSC or exported to
retrieve coordinates. For example, if the selects RUNX1
(CD34) and FLI1 (CD34), the user will retrieve sites with
combinatorial binding for RUNX1 and FLI1 in CD34+
cells. If on the other hand RUNX1 (CD34) or FLI1
(CD34) is chosen, the user will retrieve all RUNX1 coord-
inates and FLI1 coordinates in CD34+ cells. Protein–
protein and TF–gene interactions for this list can also be
visualized by following the adjacent tabs to STRING
(Supplementary Figure S2E) and Cytoscape
(Supplementary Figure S3A). Data can also be exported
into GSEA (Supplementary Figure S3B) to evaluate asso-
ciations with cellular processes or for other applications
such as generation of heatmaps using a tool of choice
(Supplementary Figure S3C). Another feature of the
database is the function to filter outputs based on differ-
ential expression between normal HSCs and more
differentiated normal blood subsets or normal HSCs and
leukaemic stem cell fractions. Binding profiles and binding
coordinates of each gene on the list can be accessed and
compared between normal HSCs and leukaemic cell lines.
DISCUSSION
Combinatorial interactions of TFs are key determinants of
cell identity (34). We have recently generated genome-wide
high resolution binding profiles for seven key haematopoi-
etic TFs in primary human CD34+ haematopoietic stem
progenitor cells (HSPCs) (9). We have now integrated
combinatorial TF binding data with quantitative gene
expression, histone modification and digital genomic foot-
printing data in these cells from the Human Epigenome
Atlas (6) and ENCODE (10) and created a user-friendly
database that allows users to (i) Interrogate overlapping
TF binding at a locus of interest, (ii) Establish binding
coordinates and associated gene targets for TFs of
interest, (iii) Compare binding profiles between cell types
and (iv) Filter lists based on differentially expressed genes.
Additional features include tools to construct visual maps
of TF–gene and protein–protein interaction networks
using links to Cytoscape (35) and STRING (16), respect-
ively. The overall aim of this database is to facilitate
enquiry into dynamic changes to the transcriptional
network of HSPCs as cells differentiate into specific
lineages or transform into leukaemic cells.
At present, we have included data sets for normal
hCD34s, primary megakaryocytes and an AML cell line
for which high-quality combinatorial TF binding data are
available. As more TF binding data are published and
where the quality of these data sets accord with
ENCODE guidelines (36), BloodChIP will be expanded
to accommodate more TF binding profiles in human
CD34+HSPCs as well as those in other normal human
blood lineages and human leukaemic cell lines. We believe
that BloodChIP, which integrates combinatorial TF
binding with gene expression in normal and malignant
cells, will be of particular interest to biologists and
bioinformaticians working in the fields of haematopoiesis
and leukaemia and also more generally to those working
on gene regulation and stem cell biology.
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